Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
about
Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesBeyond THC: The New Generation of Cannabinoid Designer DrugsSynthetic cannabinoids 2015: An update for pediatricians in clinical practiceGone to Pot - A Review of the Association between Cannabis and PsychosisSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsPhenazepam and cannabinomimetics sold as herbal highs in New ZealandExogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic reviewDistinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Recent advances in forensic drug analysis by DART-MS"Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.Rapid analysis of forensic-related samples using two ambient ionization techniques coupled to high-resolution mass spectrometers.Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish internet company.Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urineSevere toxicity following synthetic cannabinoid ingestion.Convulsions associated with the use of a synthetic cannabinoid product.Analysis of synthetic cannabinoids in "spice-like" herbal highs: snapshot of the German market in summer 2011.Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugsThe synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse.Smart drugs: green shuttle or real drug?Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with humUR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products.Novel psychoactive substances of interest for psychiatry.K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization.Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.Analysis of new designer drugs and common drugs of abuse in urine by a combined targeted and untargeted LC-HR-QTOFMS approach.Utilization of matrix-assisted laser desorption/ionization imaging mass spectrometry to search for cannabis in herb mixtures.A survey study to characterize use of Spice products (synthetic cannabinoids).
P2860
Q24631675-523CADEA-E5BB-46E9-AC95-1DE045488135Q24635230-DB991E0C-FFBE-4D02-B1E2-2B4E168FE88CQ26767016-9B4A282E-5FC9-46C3-94DA-26586DFFDEB8Q26865311-010FE946-6262-4858-98D7-067D5172D33DQ27010555-8DE2E00A-6B03-40A3-BB01-37201BDAE6F4Q28273694-4D1E6D73-1998-4354-8449-64F3E077614BQ28300877-62427406-14F7-4EA2-A613-5C7B3C4D2E33Q28540537-ADC83D5A-0B09-46F9-899E-EBAA740F880BQ29395533-8CDFCE64-F908-4BFD-977A-2A6D2C028767Q30455650-FB59C4D5-D9B2-4AE6-8F7B-9FB41354A659Q31083824-8FED360E-39D3-4F13-A41B-9632AA9A822CQ33469963-F219904D-D3D2-421E-AF50-6CE5E4E56110Q33725088-EB5DD7CC-970C-4AEB-8B00-F0CFF950B5D2Q33908169-DF5BDDAF-8899-4E62-B35E-F374B410284EQ34079088-CA6A8155-8218-4AB0-AAC9-1F36CE0C1A6CQ34115633-C68B0191-3B42-4B07-A814-15BF75BF491EQ34142699-7C9A669B-8E28-411F-8313-D448B9DFE32DQ34156299-FABF232F-E915-495E-ACE1-8B59924BEC91Q34173626-947F6DD9-F22A-4809-9909-66596E618C65Q34179558-794830AD-9D77-4141-A553-2F602E5802D7Q34194731-0473980A-6A46-4007-9522-79F090D71E59Q34240070-EE3E43C0-B371-4536-A4AB-0CDBB72A613EQ34282540-67401424-BA9B-4F2E-B327-225DBEC698FCQ34287774-94E13461-5EE0-471A-81E4-B9E6CD1FDF34Q34304330-1134C873-9E5D-4054-8FD9-D5D8FAE226D5Q34314602-71EF5BFC-1D62-4457-8037-8B7F1B90AF24Q34336690-C979DFDB-1555-4CAC-8B37-CBCF17DABEA5Q34356671-E9079E0B-81FA-41B6-9972-8BFA6B4F385CQ34419089-AA89CB66-6589-4FD3-82DD-4F4D1B897C3EQ34499556-1B7D1F1C-38A7-46E6-B23E-4E151B85A931Q34501742-DAF2930D-45AC-41FB-83D8-1DD0B597778CQ34514221-FCC10944-12EE-4627-BC84-D834F4D53D38Q34547118-37D7DDCF-E771-48DE-A733-F5AAB95BC719Q34667835-8DCE51E2-B211-49A8-9F71-A9DD4E846E6EQ35057032-98C831BA-10C0-492E-9F41-7030DEEDEAEAQ35134053-A418D41D-F222-4169-A68E-DF048BF8C526Q35164115-0B1CDF1C-B12C-4A49-8946-4DE17E7B9496Q35168771-4027E66D-2EB5-403B-AC49-54921D4454CEQ35170565-FAE66F53-178C-40C7-B215-437412623AADQ35552364-BA74AB64-C3BC-40E4-B885-12DCD31B5AEC
P2860
Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Monitoring of herbal mixtures ...... ids as psychoactive compounds.
@en
Monitoring of herbal mixtures ...... ids as psychoactive compounds.
@nl
type
label
Monitoring of herbal mixtures ...... ids as psychoactive compounds.
@en
Monitoring of herbal mixtures ...... ids as psychoactive compounds.
@nl
prefLabel
Monitoring of herbal mixtures ...... ids as psychoactive compounds.
@en
Monitoring of herbal mixtures ...... ids as psychoactive compounds.
@nl
P2093
P356
P1476
Monitoring of herbal mixtures ...... ids as psychoactive compounds.
@en
P2093
Folker Westphal
Michael Pütz
Nerea Ferreirós
Ralf Zimmermann
Sebastian Dresen
Volker Auwärter
P304
P356
10.1002/JMS.1811
P577
2010-10-01T00:00:00Z